clinical trial · NCT05695781
Assessment of the Safety and Efficacy of BRM421 Ophthalmic Solutions in Dry Eye Subjects.
Dry Eye DiseaseBRM421 Ophthalmic SolutionVehicle
brief summary
The objective of this study is to compare the safety and efficacy of BRM421 OS to vehicle for the treatment of the signs and symptoms of dry eye disease.
started
Feb 27, 2023
primary completion
Dec 30, 2023
completion
Mar 30, 2024
last updated
Jul 11, 2024
official title
A Multi-Center, Randomized, Double Masked, Vehicle Controlled Clinical Study to Assess the Safety and Efficacy of BRM421 Ophthalmic Solution in Subjects With Dry Eye Using a Controlled Adverse Environment (CAE®) Model
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol